CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Nexentis Technologies Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Nexentis Technologies Inc
HaPardes 134 (Meshek Sander), Neve Yarak
Phone: +972 3474689583p:+972 3474689583 NEW YORK, 4994500  Israel Ticker: NXTSNXTS
Business Summary
Nexentis Technologies Inc, formerly known as N2OFF, Inc., is an AI and data-driven computational biotech platform focused on mitochondrial biology, precision oncology and inflammatory metabolic diseases. Through its subsidiary MitoCareX Bio Ltd. The company uses a proprietary discovery engine targeting the mitochondrial SLC25 carrier family using its MITOLINE algorithm and structure guided virtual screening workflows. MITOLINE, its proprietary computational platform, is designed to allow proper homology modeling of mitochondrial membrane proteins, particularly transport proteins. It enables three-dimensional structural modeling and large-scale virtual screening, MITOLINE opens access to a novel untapped target space, allowing the Company to identify small-molecule modulators that directly disrupt cancer metabolism with the potential of minimizing systemic toxicity.
(Source: 6-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025YesYes--Yes

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board AmitayWeiss 65 5/24/2021 8/26/2020
Chief Executive Officer DavidPalach 57 7/15/2023 11/5/2020
Chief Financial Officer LitalBarda 36 7/15/2023 4/18/2022
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Plantify Foods Inc 2264 East 11Th Avenue VANCOUVER BC Canada

Business Names
Business Name
80W
Inc.’s equity interests in Save Foods Ltd.
MitoCareX Bio Ltd.
8 additional Business Names available in full report.

General Information
Number of Employees: 7 (As of 3/31/2026)
Outstanding Shares: 730,309 (As of 4/8/2026)
Shareholders: 183
Stock Exchange: NASD
Federal Tax Id: 264684680
Email Address: info@savefoods.co


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 28, 2026